A detailed history of Palouse Capital Management, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Palouse Capital Management, Inc. holds 2,946 shares of BDX stock, worth $668,594. This represents 0.46% of its overall portfolio holdings.

Number of Shares
2,946
Previous 2,946 -0.0%
Holding current value
$668,594
Previous $710,000 -0.0%
% of portfolio
0.46%
Previous 0.46%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$221.47 - $242.41 $25,469 - $27,877
-115 Reduced 3.76%
2,946 $710,000
Q2 2024

Aug 12, 2024

BUY
$225.07 - $246.17 $129,865 - $142,040
577 Added 23.23%
3,061 $715,000
Q1 2024

May 15, 2024

SELL
$233.45 - $247.73 $49,958 - $53,014
-214 Reduced 7.93%
2,484 $614,000
Q4 2023

Jan 31, 2024

BUY
$232.24 - $267.23 $2,786 - $3,206
12 Added 0.45%
2,698 $657,000
Q3 2023

Oct 23, 2023

BUY
$254.9 - $283.59 $1,274 - $1,417
5 Added 0.19%
2,686 $694,000
Q2 2023

Aug 08, 2023

SELL
$238.39 - $265.32 $164,727 - $183,336
-691 Reduced 20.49%
2,681 $707,000
Q1 2023

May 15, 2023

SELL
$229.71 - $259.35 $77,641 - $87,660
-338 Reduced 9.11%
3,372 $834,000
Q4 2022

Feb 13, 2023

SELL
$218.29 - $256.91 $10,914 - $12,845
-50 Reduced 1.33%
3,710 $943,000
Q3 2022

Oct 21, 2022

SELL
$51.03 - $264.23 $23,677 - $122,602
-464 Reduced 10.98%
3,760 $838,000
Q2 2022

Jul 28, 2022

SELL
$234.74 - $275.42 $14,319 - $16,800
-61 Reduced 1.42%
4,224 $1.04 Million
Q1 2022

Apr 21, 2022

SELL
$243.64 - $270.48 $24,364 - $27,048
-100 Reduced 2.28%
4,285 $1.14 Million
Q4 2021

Jan 25, 2022

BUY
$230.08 - $250.94 $8,743 - $9,535
38 Added 0.87%
4,385 $1.1 Million
Q3 2021

Oct 21, 2021

SELL
$232.72 - $256.47 $32,348 - $35,649
-139 Reduced 3.1%
4,347 $1.07 Million
Q2 2021

Jul 28, 2021

BUY
$232.65 - $254.58 $1.04 Million - $1.14 Million
4,486 New
4,486 $1.09 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.7B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Palouse Capital Management, Inc. Portfolio

Follow Palouse Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palouse Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Palouse Capital Management, Inc. with notifications on news.